Bladder Cancer Clinical Trials | Norton Healthcare Louisville, Ky.

Bladder Cancer and Urothelial Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments and numerous bladder cancer clinical trials.

Learn more about participating in a clinical trial at Norton Healthcare.

Active bladder cancer and urothelial cancer clinical trials include:

Genitourinary Cancer

A phase III, multicenter, randomized, placebo-controlled, double-blind study of atezolizumab (anti-pd-l1 antibody) in combination with gemcitabine/carboplatin versus gemcitabine/carboplatin alone in patients with untreated locally advanced or metastatic u

Genitourinary Cancer

A Phase 3 Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations

Genitourinary Cancer

A Phase Ib/II Open Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Locally Advanced Or Metastatic Urothelial Carcinoma After Failure With Platinum-Con

Genitourinary Cancer

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

Genitourinary Cancer

A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durvalumab Alone for Adjuvant Treatment in Patients with Mus

Genitourinary Cancer

A Phase III, Randomized, Open Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab and Standard of Care Chemotherapy Versus Standard of Car

Genitourinary Cancer

An open-label multi-cohort Phase 1b/2 study of derazantinib and atezolizumab in patients with urothelial cancer expressing activating molecular FGFR aberrations (FIDES-02)

Genitourinary Cancer

A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) versus CRT Alone in Participants with Muscle-invasive Bladder Cancer (MIBC) (KEY

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3500

On-site genomic testing at Norton Cancer Institute will allow fast and precise treatment

Thanks to the Steven Vanover Foundation and other caring community supporters, Norton Cancer Institute will have specialized laboratory capabilities and equipment to perform on-site genomic testing. This highly specialized testing will make it possible to diagnose and […]

Read Full Story

Don’t let COVID-19 get in the way of your mammogram

Now, more than ever, is a time to take control of your health. With October marking Breast Cancer Awareness Month, take the time to schedule your annual mammogram. Increased steps to prevent infection at seven […]

Read Full Story

Is an at-home colon cancer test right for you?

The COVID-19 pandemic has presented many challenges, including delays in some health care visits. That’s why at Norton Healthcare, we’ve made it easy for you to take control of your health from home. For those […]

Read Full Story

12 years and lots of biking raises more than $100,000 for Norton Cancer Institute

Twelve years ago, Jeremy Sprecher registered to ride his bike to Lexington and back as part of the first Bike to Beat Cancer in support of Norton Cancer Institute. Even greater than the challenge of […]

Read Full Story

Marisela Cervantes rides in Bike to Beat Cancer for her wife, sister and a friend

When Marisela Cervantes first rode in Bike to Beat Cancer four years ago, she started with the family ride.  She rode in honor of Annette Conrad, a friend of a friend who was receiving help from […]

Read Full Story
Related Stories

On-site genomic testing at Norton Cancer Institute will allow fast and precise treatment

Thanks to the Steven Vanover Foundation and other caring community supporters, Norton Cancer Institute will have specialized laboratory capabilities and equipment to perform on-site genomic testing. This highly specialized testing will make it possible to diagnose and […]

Read Full Story

Don’t let COVID-19 get in the way of your mammogram

Now, more than ever, is a time to take control of your health. With October marking Breast Cancer Awareness Month, take the time to schedule your annual mammogram. Increased steps to prevent infection at seven […]

Read Full Story

Is an at-home colon cancer test right for you?

The COVID-19 pandemic has presented many challenges, including delays in some health care visits. That’s why at Norton Healthcare, we’ve made it easy for you to take control of your health from home. For those […]

Read Full Story

12 years and lots of biking raises more than $100,000 for Norton Cancer Institute

Twelve years ago, Jeremy Sprecher registered to ride his bike to Lexington and back as part of the first Bike to Beat Cancer in support of Norton Cancer Institute. Even greater than the challenge of […]

Read Full Story

Marisela Cervantes rides in Bike to Beat Cancer for her wife, sister and a friend

When Marisela Cervantes first rode in Bike to Beat Cancer four years ago, she started with the family ride.  She rode in honor of Annette Conrad, a friend of a friend who was receiving help from […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.